Quanterix (QTRX) Cash from Operations (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.11% |
| Dec 31, 2025 | 60.13% |
| Sep 30, 2025 | -629.43% |
| Jun 30, 2025 | 59.28% |
| Mar 31, 2025 | -222.83% |
| Dec 31, 2024 | 25.14% |
| Sep 30, 2024 | -16.08% |
| Jun 30, 2024 | 75.45% |
| Mar 31, 2024 | -225.65% |
| Dec 31, 2023 | -60.17% |
| Sep 30, 2023 | -474.25% |
| Jun 30, 2023 | 110.52% |
| Mar 31, 2023 | -140.20% |
| Dec 31, 2022 | 72.37% |
| Sep 30, 2022 | -85.97% |
| Jun 30, 2022 | 63.41% |
| Mar 31, 2022 | -117.42% |
| Dec 31, 2021 | 27.37% |
| Sep 30, 2021 | -41.32% |
| Jun 30, 2021 | 30.80% |
| Mar 31, 2021 | -402.73% |
| Dec 31, 2020 | 162.73% |
| Sep 30, 2020 | 0.03% |
| Jun 30, 2020 | 43.69% |
| Mar 31, 2020 | -190.61% |
| Dec 31, 2019 | 48.65% |
| Sep 30, 2019 | -18.26% |
| Jun 30, 2019 | -39.54% |
| Mar 31, 2019 | 33.99% |
| Dec 31, 2018 | -22.05% |
| Sep 30, 2018 | -69.94% |
| Jun 30, 2018 | 61.15% |
| Mar 31, 2018 | -128.56% |
| Dec 31, 2017 | 41.19% |
| Sep 30, 2017 | -20.20% |
| Jun 30, 2017 | -55.99% |